CAR T therapy multiple sclerosis trial death: Bristol Myers Squibb disclosed the first fatality in its Phase 1 Breakfree-2 ...

As the publisher searches for a new CEO, insiders blame an exodus of senior sales talent and a lack of clear commercial ...

IMA402 PRAME bispecific continues to demonstrate encouraging anti-tumor activity in multiple indications, alongside a ...

Topline data readout from APPROACH Phase 3 study of HLP003 in development for the potential adjunctive treatment of major ...

SOAR AI, Inc. (NYSE American: SOAR) ("SOAR AI" or the "Company"), today announced that it has released an updated investor presentation providing an overview of its AI infrastructure business, ...

An announcement from Emerge Commerce Ltd ( ) is now available. EMERGE Commerce Ltd., a TSXV-listed consolidator of profitable e-commerce brands, operates a portfolio spanning Dire ...

BioVie Inc. (NASDAQ: BIVI) (?BioVie? or the ?Company?) announced the Company has been invited to present at the 2026 RECOVER?Treating Long COVID (RECOVER-TLC) Hybrid Workshop, hosted by the National ...

Fashion ecommerce teams often evaluate photography by looking at the economics of the cost of a shoot, the number of images ...

SUN-627 demonstrated favorable safety, tolerability, and pharmacokinetics for oral, once-daily dosing in healthy ...

Good morning, everyone, and welcome to Baker Hughes Third Quarter Earnings Conference Call. Here with me are our C ...

Early clinical data from the Phase 1 theranostic trial support the advancement of ATNM-400 as a non-PSMA targeted alpha therapy for metastatic castration-resistant prostate cancer Evaluation ...

"While all of these skills matter, to me, business development is the most important. I think of it as relationship ...